se of a real time continuous glucose monitoring system (RT-CGMS) in type 1 diabetes patients on continuous intraperitoneal insulin infusion (CIPII). A feasibility study.

Recruiting

• Conditions: diabetes; blood glucose regulation; 10018424

• Registration Number: NL-OMON31251
• Lead Sponsor: Isala Klinieken

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 12

Inclusion Criteria

Patients on CIPII and treated in the Isala Clinic, Zwolle, The Netherlands.
Age >18 years
Uncontrolled diabetes mellitus type 1; HbA1c at last measurement (not longer than 6 weeks ago) >7.5% and/or >5 hypoglycaemic events /week as measured by SMBG.

Exclusion Criteria

Failure to obtain informed consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>percentage of time spent in euglycaemia</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>percentage of time spent in hypoglycaemia and hyperglycaemia.<br /><br>incidence of hypoglycaemia<br /><br>incidence of adverse effects<br /><br>Number of SMBG performed<br /><br>Number of adjustments of insulin therapy.<br /><br>Patient satisfaction</p><br>